Biora Therapeutics (NASDAQ:BIOR – Get Free Report) and Sarepta Therapeutics (NASDAQ:SRPT – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, analyst recommendations, institutional ownership, profitability and risk. Analyst Recommendations This is a breakdown of current […]
SAN DIEGO, Oct. 05, 2023 (GLOBE NEWSWIRE) Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, presented data on oral delivery of a GLP-1 receptor
HC Wainwright & Co. has decided to maintain its Buy rating of Biora Therapeutics BIOR and lower its price target from $65.00 to $50.00. Shares of Biora…
On September 25, California Attorney General (AG) Rob Bonta announced a settlement with Biora Therapeutics, Inc. (Biora) regarding misleading claims the company made concerning the cost.